Physician profile
Heather E Doss
NPI 1043500275
$439.82
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $263 · 2020: $49.81 · 2022: $127.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $196.51 | 2019-2022 | |
| Genentech USA, INC. | $42.92 | 2019-2020 | |
| Pfizer INC. | $37.98 | 2019 | |
| Amgen INC. | $37.75 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $37.38 | 2019-2020 | |
| Cranial Technologies, INC | $33.85 | 2019-2020 | |
| Fidia Pharma USA INC. | $18.27 | 2019 | |
| Boston Scientific Corporation | $13.10 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $11.15 | 2019 | |
| Lilly USA, LLC | $10.91 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Doss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.